Bridger Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Bridger Management, LLC

$194 Million
Q2 2024

A detailed history of Bridger Management, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Bridger Management, LLC holds 37,022 shares of ALNY stock, worth $10.4 Million. This represents 4.63% of its overall portfolio holdings.

Number of Shares

37,022

Previous 52,922 30.04%

Holding current value

$10.4 Million

Previous $7.91 Million 13.74%

% of portfolio

4.63%

Previous 3.57%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $2.28 Million - $3.93 Million	-15,900 Reduced 30.04%	37,022 $9 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $7.75 Million - $10.5 Million	52,922 New	52,922 $7.91 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $2.86 Million - $3.72 Million	18,922 New	18,922 $3.62 Million
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $9.54 Million - $12.5 Million	-59,804 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $8.74 Million - $10.7 Million	-51,500 Reduced 46.27%	59,804 $11.3 Million
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $14.8 Million - $20.4 Million	-115,200 Reduced 50.86%	111,304 $18.9 Million
Q1 2021 May 14, 2021	SELL	$126.83 - $175.69 $11.1 Million - $15.3 Million	-87,128 Reduced 27.78%	226,504 $32 Million
Q4 2020 Feb 16, 2021	SELL	$122.97 - $147.0 $5.61 Million - $6.7 Million	-45,602 Reduced 12.69%	313,632 $40.8 Million
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $1.22 Million - $1.82 Million	11,661 Added 3.35%	359,234 $53.2 Million
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $11.2 Million - $16.1 Million	-120,345 Reduced 25.72%	347,573 $37.8 Million
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $8.65 Million - $14.4 Million	116,157 Added 33.02%	467,918 $53.9 Million
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $19.5 Million - $24.1 Million	-274,955 Reduced 43.87%	351,761 $28.3 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $280,958 - $395,842	4,266 Added 0.69%	626,716 $45.5 Million
Q1 2019 May 15, 2019	SELL	$72.76 - $93.45 $2.64 Million - $3.4 Million	-36,335 Reduced 5.52%	622,450 $58.2 Million
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $4.02 Million - $5.67 Million	-64,225 Reduced 8.88%	658,785 $48 Million
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $7.05 Million - $9.88 Million	80,544 Added 12.54%	723,010 $63.3 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $8.2 Million - $10 Million	92,834 Added 16.89%	642,466 $63.3 Million
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $5.73 Million - $7.34 Million	49,413 Added 9.88%	549,632 $65.5 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $13.3 Million - $16.3 Million	116,286 Added 30.29%	500,219 $63.6 Million
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $27.8 Million - $45.4 Million	383,933	383,933 $45.1 Million

Others Institutions Holding ALNY

# of Institutions

636

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.15M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $34.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridger Management, LLC with notifications on news.

Account

Bridger Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History